GlassScriptPhysician profile
Jennifer Maw
NPI 1609989417
$1,673.59
in general payments reported to CMS, 2019-2025
12 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2021: $80.65 · 2022: $124 · 2023: $276 · 2024: $452 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $366.42 | 2019-2023 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Advanced Bionics, LLC | $245.28 | 2019 | |
| Cochlear Americas | $233.97 | 2024-2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Neurent Medical Limited | $200.75 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Pfizer INC. | $142.34 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $124.60 | 2019 | |
| Medtronic, INC. | $91.33 | 2023 | Percept PC Brainsense |
| Abbvie INC. | $74.18 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $25.99 | 2021 | |
| Optinose US, INC. | $22.40 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Maw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.